Akebia Therapeutics reported 26.5 in PE Price to Earnings for its fiscal quarter ending in September of 2023.





Pe Change Date
Acadia Pharmaceuticals 11.61 2.09 Dec/2025
Agios Pharmaceuticals 3.56 0.68 Sep/2025
Akebia Therapeutics 26.5 0.19 Sep/2023
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amgen 25.31 15.82 Dec/2025
Astellas Pharma 7.31 2.04 Dec/2025
AstraZeneca 27.29 5.8 Dec/2025
Bayer 5.93 0.68 Sep/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Celltrion 50.09 23.24 Sep/2025
Cspc Pharmaceutical 25.53 3.8 Sep/2025
Deva Holding AS 6.55 2.01 Sep/2023
Exelixis 602.31 586.25 Dec/2025
Fresenius Medical Care 8.71 1.86 Dec/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Ironwood Pharmaceuticals 204.24 88.19 Dec/2024
J&J 23.62 0.86 Dec/2025
Kangmei Pharma 3.15K 624.19 Jun/2025
Knight Therapeutics 91.09 0.73 Sep/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Lexicon Pharmaceuticals 12.44 4.73 Jun/2021
Malin Corporation 11.81 0.72 Jun/2023
Moderna 27.22 14.51 Jun/2023
Neuren Pharmaceuticals 72.14 59.86 Dec/2025
Organigram Holdings 235 224.49 Sep/2025
Ovoca Bio 1.83 3.29 Jun/2024
Pharma Mar 17.41 29.74 Dec/2025
Prothena 22.11 11.37 Mar/2022
PTC Therapeutics 9.98 3.25 Dec/2025
Qiagen NV 20.54 0.1 Dec/2025
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Sanofi 11.99 1.58 Dec/2025
Sarepta Therapeutics 27.27 0 Sep/2025
Sartorius 34.42 122.1 Sep/2025
Sino Biopharmaceutical 17.03 0.89 Jun/2025
Tectonic Therapeutic 4.01 0.63 Mar/2024
Vanda Pharmaceuticals 16.79 7.07 Jun/2023
Zz Pientze Pharmaceu 49.04 4.33 Sep/2025